Filana Therapeutics

FLNANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$48.066 M

$1.00 +3.75%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$91.0M

Loss-making

Shares outstanding

48,307,896

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#351Alaunos TherapeuticsTCRT$48.6M
#352Seres TherapeuticsMCRB$48.4M
#353Filana TherapeuticsFLNA$48.1M
#354Karyopharm TherapeuticsKPTI$48.0M
#355Impact BiomedicalIBO$46.9M

Where these numbers come from

Share counts and financials for Filana Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.